---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Schrödinger

🌎 schrodinger.com

Schrödinger is a leading scientific software and biotechnology company that specializes in developing advanced computational tools for drug discovery and materials science. Founded in 1990 and headquartered in New York, Schrödinger's platform supports biopharmaceutical and industrial research globally, with a commitment to innovation in molecular discovery and design.

---

Schrödinger - Latest News and Updates

• Schrödinger introduced a next-generation tool, FEP+ Residue Scan, offering a 15x speedup in protein engineering predictions, and announced the discovery of KAI-11101, a preclinical DLK inhibitor for neurodegenerative diseases.
• Schrödinger has entered a research collaboration and license agreement with Novartis worth over $2 billion to develop small molecule candidates and signed a three-year software agreement to enhance Novartis' access to Schrödinger's technology.
• Schrödinger added a new role for a Materials Science Account Manager in the United States and a Director of Ventures in New York.
• The Indiana Biosciences Research Institute uses Schrödinger's platform to enhance drug discovery and optimize molecular therapeutics.
• Schrödinger is currently seeking a Director of Ventures in the United States.

• Schrödinger software was used in a study to identify Eriocitrin as a strong binder to CDK1 for potential colorectal cancer treatment.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.